Intesa Sanpaolo S.p.A.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1374384 TURIN, L6

Position in HALO

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$602,757

+$146,470 QoQ

Shares Held

7,701

+9.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#363

of 664 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Intesa Sanpaolo S.p.A. holds $1,347,981 across 4 Biotechnology names. HALO ranks #1 (44.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc. This page	7,701	$602,757
2	REGN	Regeneron Pharmaceuticals, Inc.	670	$417,771
3	MRNA	Moderna, Inc.	2,434	$170,453
4	ABCL	AbCellera Biologics Inc.	20,000	$157,000

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$602,757	7,701	+9.1%	Shares	Defined	2026-07-31
2026-03-31	$456,287	7,060	-39.5%	Shares	Defined	2026-05-15
2025-12-31	$784,718	11,660	—	Shares	Defined	2026-02-17
No filing history on record for this holder in this stock.